Here are the 8-K filings from GP-Act III Acquisition Corp. Units (GPATU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow GPATU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GPATU filings page.
GP-Act III Acquisition Corp. (GPAT) agreed on November 3, 2026, to combine with Dronamics Group Limited. The agreement sets merger consideration at 40,000,000 Holdco common shares, allocated among eligible Newco shares on a fully diluted basis. Dronamics has a US$400 million pre-money equity value and estimated pro forma enterprise value of approximately US$500 million; existing shareholders are expected to roll over 100% of their equity.
The transaction targets approximately US$100 million in net cash proceeds for Dronamics at closing, after transaction expenses, from GPAT trust cash and potential PIPE financing, subject to shareholder redemptions and PIPE commitments. Closing requires shareholder approvals, an effective registration statement, regulatory clearances and at least US$25 million in net closing cash. Completion is expected in the first half of 2027; either party may terminate if closing has not occurred by May 8, 2027, subject to exceptions. Dronamics said it had not begun commercial revenue operations and had generated no meaningful product or service revenue as of November 2026.
GP-Act III Acquisition Corp. outlines plans to enter into non-redemption agreements with one or more third-party shareholders to support extending its deadline to complete a business combination. The proposed Extension Amendment and Trust Amendment would move the current May 13, 2026 termination dates to November 13, 2026.
In these non-redemption agreements, shareholders would agree not to redeem specified Class A ordinary shares and to vote in favor of the extension proposals. In return, GP-Act III Sponsor LLC anticipates transferring a negotiated number of Class A ordinary shares to these investors after the initial business combination closes.
GP-Act III Acquisition Corp. held an extraordinary general meeting on May 6, 2026 and shareholders approved adjourning the meeting to allow more time to solicit proxies on two key extension proposals. The adjournment proposal passed with 21,424,593 votes for, 8,064,137 against and 1,000 abstentions.
The adjourned meeting is scheduled for May 12, 2026, when shareholders will vote on extending the deadline to complete a business combination and to liquidate the SPAC’s trust account from May 13, 2026 to November 13, 2026. Holders who previously elected to redeem their Class A shares are permitted to reverse those redemption requests by contacting the transfer agent by 9:00 a.m. Eastern Time on May 12, 2026.
GP-Act III Acquisition Corp. adjourned its extraordinary general meeting held on April 29, 2026 after shareholders approved an adjournment proposal to allow more time to solicit proxies. The meeting will reconvene on May 6, 2026 to vote on extending its business combination deadline and related trust agreement from May 13, 2026 to November 13, 2026.
Of 35,937,500 ordinary shares outstanding on the March 24, 2026 record date, 81.67% were represented, and the adjournment proposal received 21,313,393 votes for, 8,034,735 against and 1,000 abstentions. Shareholders who previously elected to redeem their public Class A shares may reverse their redemption requests by contacting the transfer agent by 9:00 a.m. Eastern Time on May 6, 2026.